2022 Scientific Retreat- Session 9

Session 9: Combining Immunomodulatory Treatments for Prostate Cancer 
29th Annual PCF Scientific Retreat: October 29, 2022 | 7:00 AM – 8:40 AM 

Moderator: Nicholas Huntington, PhD 
Monash University, Australia 

Targeting P53 to Induce ICB Response in Cold Tumors 
Nicholas Huntington, PhD 
Monash University, Australia 

Engaging FLT3 to Promote Dendritic Cell Expansion & Drive the Adaptive Anti-Tumor Immune Response 
Michelle Kuhne, PhD 
Gilead Sciences 

Leveraging an Interplay Between Hormone Receptor Signaling and Immune Recognition to Enhance Immunotherapy in Prostate Cancer 
Lisa Chesner, PhD 
University of California, San Francisco 

EZH2 Inhibition Reprograms the Tumor Microenvironment to Potentiate Response to Checkpoint Inhibition 
Leigh Ellis, PhD 
Cedars Sinai Medical Center